Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2022HeliyonOpen Access

Synthesis, α-glucosidase inhibition, α-amylase inhibition, and molecular docking studies of 3,3-di(indolyl)indolin-2-ones

View Full Paper
Ask AI
Bookmark
Share

Authors

MSMardi SantosoSepuluh Nopember Institute of TechnologyLOLi Lin OngNanyang Technological UniversityNANur Pasca Aijijiyah

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Santoso et al. (2022) studied this question.

synapsesocial.com/papers/6ab768a5dfd7aad490b392e0https://doi.org/10.1016/j.heliyon.2022.e09045
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mini-Special Issue paper Management of diabetic patients with hypoglycemic agents α-Glucosidase inhibitors and their use in clinical practice2012 · 428 citations
  2. 2Efficacy and Safety of Acarbose in Insulin-Treated Patients With Type 2 Diabetes1998 · 166 citations
  3. 3Facile and One-Pot Access of 3,3-Bis(indol-3-yl)indolin-2-ones and 2,2-Bis(indol-3-yl)acenaphthylen-1(2H)-one Derivatives via an Eco-Friendly Pseudo-Multicomponent Reaction at Room Temperature Using Sulfamic Acid as an Organo-Catalyst2014 · 85 citations